Error message

The page you requested does not exist. For your convenience, a search was performed using the query what we do special interest groups clinical ethics.

Page not found

You are here

This two-day conference took place on the UM campus and is presented by the University of Michigan Medical School.  It was also supported by the Office of the Vice President for Research; the Center for Ethics and Public Life; Rackham Distinguished Faculty Grant; Greenwall Foundation; and Institute for Social Policy and Understanding.  Click here for conference videos, course packets, and reference materials. 

CBSSM co-sponsored the 15th Annual Waggoner Bioethics Lecture on November 3, 2010, hosting a breakfast in honor of the speaker, Dr. Bernard Lo, Director of the Program in Medical Ethics at UCSF.  The Waggoner lecture is organized by the Department of Psychiatry in honor of Dr. Raymond Waggoner, chair of the department from 1937 to 1970.

Be sure to post a comment at peterubel.com, the blog of the former CBSSM director, Peter A. Ubel, MD. Dr. Ubel's commentaries range across science, policy, health, well-being, and ethics. Topics include bankruptcy, behavior, and building; nuances, nature, and neighborhoods; soccer, satire, and scientocracy.

Joel Howell, MD, PhD, was awarded the American College of Physicians (ACP) Nicholas E. Davies Memorial Scholar Award for Scholarly Activities in the Humanities and History of Medicine for 2013.

This award is given for outstanding contributions to humanism in medicine and will be bestowed in recognition of scholarly activities in history, literature, philosophy and ethics. The award is described in detail at ACP‘s website.

Drs.  Shuman, Vercler, De Vries and Firn have been awarded a CME Innovations Grant from the Office of Continuous Professional Development to develop a multidisciplinary ethics curriculum for practicing clinicians across UMHS critical care units.

Naomi Laventhal was appointed to the American Academy of Pediatrics (AAP) Committee on Bioethics. She also serves as the liason to the Executive Committee of the AAP Section on Bioethics (which is the educational/outreach arm) and edits the “ethics case of the month” listserv for AAP.

Bioethics Grand Rounds - Dr. Michael Jibson

Wed, August 26, 2015, 12:00pm
Location: 
Ford Auditorium

This month's grand rounds features: Michael Jibson, MD, Psychiatry Department speaking about "Psychiatry, Law, and Society: Ethical and Legal Issues in Mental Health"

Lunch provided!

Please join us for a lively discussion of medical ethics. The Bioethics Grand Rounds is co-sponsored by the Center for Bioethics and Social Sciences in Medicine, the UMHS Adult and Pediatric Medical Ethics Committee, and the Program of Society and Medicine. This educational session is open to all faculty and staff and members of the public. CME credit is available. 

To meet ACCME requirements for Faculty Planner disclosure and Presenter Disclosure to participants of CME activities at UM, please be advised that the following faculty planner(s)/co-planner(s) and presenter have no personal financial relationships relevant to the activity listed below:
Planners: 

  • Andrew Shuman, MD
  • Christian Vercler, MD
Fri, April 10, 2015

Dr. Jagsi was interviewed by MedicalResearch.com, discussing her study which finds many breast cancer patients have an unmet need to discuss genetic testing with their healthcare provider. The study found that 35 percent of women with breast cancer expressed a strong desire for genetic testing, but 43 percent of those women did not have a relevant discussion with a healthcare professional. "By more routinely addressing genetic risk with patients, we can better inform them of their true risk of cancer returning or of developing a new cancer," Dr. Jagsi explains in the interview. "This could potentially alleviate worry and reduce confusion about cancer risk."

Geoffrey Barnes is lead author on study published in the American Journal of Medicine finding new anticoagulants are driving increase in atrial fibrillation treatment and reducing warfarin therapy use.

“The data provides a promising outlook about atrial fibrillation which is known for being undertreated,” says lead author Geoffrey Barnes, M.D., MSc.,  cardiologist at the University of Michigan Health System and researcher at the Institute for Healthcare Policy and Innovation.  “When we don’t treat atrial fibrillation, patients are at risk for stroke. By seeking treatment, patients set themselves up for better outcomes.”

More details can be found here.

Funded by National Institutes of Health; National Institute on Aging

Funding Years: 2012-2017

This is competing continuation proposal for Years 23-28 of the Health and Retirement Study (HRS) cooperative agreement, in response to NIA RFA #AG-12-001. We propose to continue core data collection on the steady-state design laid out in the two previous renewal cycles, and collect biomarkers and measures of physical performance in in-person interviews on the rotating half-sample design established in the previous cycle.

PI(s): Sharon Kardia

Co-I(s):  Kenneth Langa, Charles Brown, David Weir, Helen Levy, John Bound, James House, Mick Couper, Sunghee Lee

Pages